RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 128 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,605,973 | +48.6% | 6,876,598 | +45.1% | 0.40% | +71.8% |
Q2 2023 | $35,396,723 | +48.4% | 4,738,517 | +32.5% | 0.23% | +42.7% |
Q1 2023 | $23,857,670 | -0.2% | 3,576,862 | +15.4% | 0.16% | -20.8% |
Q4 2022 | $23,897,068 | -33.2% | 3,099,490 | -7.7% | 0.21% | -16.9% |
Q3 2022 | $35,748,000 | +113.8% | 3,359,811 | +23.0% | 0.25% | +151.5% |
Q2 2022 | $16,720,000 | -17.4% | 2,732,087 | -3.4% | 0.10% | +17.9% |
Q1 2022 | $20,242,000 | -47.1% | 2,827,163 | +26.7% | 0.08% | -27.6% |
Q4 2021 | $38,234,000 | -35.9% | 2,232,013 | -13.9% | 0.12% | -18.9% |
Q3 2021 | $59,684,000 | -31.3% | 2,593,836 | +9.0% | 0.14% | -11.7% |
Q2 2021 | $86,822,000 | – | 2,378,675 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |